Investors with a lot of money to spend have taken a bullish stance on Recursion Pharmaceuticals RXRX.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RXRX, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 15 uncommon options trades for Recursion Pharmaceuticals.
This isn't normal.
The overall sentiment of these big-money traders is split between 60% bullish and 40%, bearish.
Out of all of the special options we uncovered, 7 are puts, for a total amount of $261,224, and 8 are calls, for a total amount of $327,927.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $7.5 to $10.0 for Recursion Pharmaceuticals over the last 3 months.
Volume & Open Interest Development
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Recursion Pharmaceuticals's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Recursion Pharmaceuticals's significant trades, within a strike price range of $7.5 to $10.0, over the past month.
Recursion Pharmaceuticals Option Volume And Open Interest Over Last 30 Days
Significant Options Trades Detected:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RXRX | CALL | SWEEP | BULLISH | 01/17/25 | $2.1 | $2.0 | $2.1 | $9.00 | $56.9K | 1 | 919 |
| RXRX | CALL | SWEEP | BULLISH | 01/17/25 | $2.1 | $2.0 | $2.09 | $9.00 | $56.8K | 1 | 646 |
| RXRX | PUT | SWEEP | BEARISH | 01/17/25 | $1.85 | $1.75 | $1.85 | $7.50 | $50.3K | 1.2K | 719 |
| RXRX | PUT | SWEEP | BEARISH | 01/17/25 | $1.85 | $1.75 | $1.85 | $7.50 | $50.0K | 1.2K | 446 |
| RXRX | CALL | SWEEP | BULLISH | 01/17/25 | $2.15 | $2.0 | $2.15 | $9.00 | $43.0K | 1 | 200 |
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
After a thorough review of the options trading surrounding Recursion Pharmaceuticals, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Where Is Recursion Pharmaceuticals Standing Right Now?
- With a trading volume of 2,960,648, the price of RXRX is up by 0.13%, reaching $7.85.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 14 days from now.
Expert Opinions on Recursion Pharmaceuticals
In the last month, 1 experts released ratings on this stock with an average target price of $17.0.
- An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $17.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Recursion Pharmaceuticals options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
